IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID ROSENTHAL

Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry

NPI
1104195817
CMS profile
140449
Location
BOULDER, CO

General Payments · PY2018–2024

$10,171.27

  • Reported across 339 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,957.82

53 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Psychiatry CO All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,945.67 52
Education $12.15 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Vanda Pharmaceuticals Inc. $304.41 8
Neurocrine BioSciences, Inc. $285.76 4
Alkermes, Inc. $266.59 8
ITI, Inc. $255.94 10
Axsome Therapeutics, Inc. $225.41 2
IRONSHORE PHARMACEUTICALS INC. $165.93 8
ABBVIE INC. $154.09 5
E.R. Squibb & Sons, L.L.C. $125.92 2
Tris Pharma Inc $83.12 1
Corium, Inc. $62.31 3
IDORSIA PHARMACEUTICALS US INC $14.35 1
Noven Therapeutics, LLC $13.99 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,396.26 53
PY2019 $1,588.13 54
PY2020 $546.48 25
PY2021 $1,645.31 56
PY2022 $1,289.63 46
PY2023 $1,747.64 52
PY2024 $1,957.82 53

Payment records · PY2024 (53)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $116.73 03/06/2024 Food and Beverage Undisputed 01/23/2026 1105976886 CMS
ABBVIE INC. $6.39 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105976888 CMS
ABBVIE INC. $7.56 07/30/2024 Food and Beverage Undisputed 01/23/2026 1105976890 CMS
ABBVIE INC. $5.93 07/30/2024 Food and Beverage Undisputed 01/23/2026 1105976892 CMS
ABBVIE INC. $17.48 10/31/2024 Food and Beverage Undisputed 01/23/2026 1105976894 CMS
Alkermes, Inc. $18.96 01/09/2024 Food and Beverage Undisputed 01/23/2026 1120584324 CMS
Alkermes, Inc. $26.34 02/15/2024 Food and Beverage Undisputed 01/23/2026 1120584326 CMS
Alkermes, Inc. $25.62 03/27/2024 Food and Beverage Undisputed 01/23/2026 1120584328 CMS
Alkermes, Inc. $108.23 05/01/2024 Food and Beverage Undisputed 01/23/2026 1120584330 CMS
Alkermes, Inc. $23.24 06/19/2024 Food and Beverage Undisputed 01/23/2026 1120584332 CMS
Alkermes, Inc. $17.10 08/07/2024 Food and Beverage Undisputed 01/23/2026 1120584334 CMS
Alkermes, Inc. $31.53 10/02/2024 Food and Beverage Undisputed 01/23/2026 1120584336 CMS
Alkermes, Inc. $15.57 12/05/2024 Food and Beverage Undisputed 01/23/2026 1120584338 CMS
Axsome Therapeutics, Inc. $102.00 05/07/2024 Food and Beverage Undisputed 01/23/2026 1148275976 CMS
Axsome Therapeutics, Inc. $123.41 10/03/2024 Food and Beverage Undisputed 01/23/2026 1148275978 CMS
Corium, LLC $19.63 02/13/2024 Food and Beverage Undisputed 01/23/2026 1100098956 CMS
Corium, LLC $21.96 04/11/2024 Food and Beverage Undisputed 01/23/2026 1100091594 CMS
Corium, LLC $20.72 06/26/2024 Food and Beverage Undisputed 01/23/2026 1100179808 CMS
E.R. Squibb & Sons, L.L.C. $20.11 10/03/2024 Food and Beverage Undisputed 01/23/2026 1101510724 CMS
E.R. Squibb & Sons, L.L.C. $105.81 11/05/2024 Food and Beverage Undisputed 01/23/2026 1101510792 CMS
IDORSIA PHARMACEUTICALS US INC $14.35 01/19/2024 Food and Beverage Undisputed 01/23/2026 1146763372 CMS
IRONSHORE PHARMACEUTICALS INC. $21.96 01/17/2024 Food and Beverage Undisputed 01/23/2026 1146251231 CMS
IRONSHORE PHARMACEUTICALS INC. $21.96 02/09/2024 Food and Beverage Undisputed 01/23/2026 1146251263 CMS
IRONSHORE PHARMACEUTICALS INC. $20.66 02/29/2024 Food and Beverage Undisputed 01/23/2026 1146251347 CMS
IRONSHORE PHARMACEUTICALS INC. $23.58 04/24/2024 Food and Beverage Undisputed 01/23/2026 1146251183 CMS
IRONSHORE PHARMACEUTICALS INC. $16.11 05/22/2024 Food and Beverage Undisputed 01/23/2026 1146243771 CMS
IRONSHORE PHARMACEUTICALS INC. $21.30 07/24/2024 Food and Beverage Undisputed 01/23/2026 1146246353 CMS
IRONSHORE PHARMACEUTICALS INC. $20.34 10/29/2024 Food and Beverage Undisputed 01/23/2026 1146319003 CMS
IRONSHORE PHARMACEUTICALS INC. $20.02 12/04/2024 Food and Beverage Undisputed 01/23/2026 1146322915 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.20 01/31/2024 Food and Beverage Undisputed 01/23/2026 1143310014 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $103.74 03/18/2024 Food and Beverage Undisputed 01/23/2026 1143310017 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.44 03/19/2024 Food and Beverage Undisputed 01/23/2026 1143310021 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.75 04/10/2024 Food and Beverage Undisputed 01/23/2026 1143310025 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.54 05/10/2024 Food and Beverage Undisputed 01/23/2026 1143310028 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.15 05/15/2024 Education Undisputed 01/23/2026 1143310032 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $26.99 06/25/2024 Food and Beverage Undisputed 01/23/2026 1143310036 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $18.01 07/17/2024 Food and Beverage Undisputed 01/23/2026 1143310039 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $17.51 10/07/2024 Food and Beverage Undisputed 01/23/2026 1143310043 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $8.61 11/09/2024 Food and Beverage Undisputed 01/23/2026 1143310047 CMS
Neurocrine Biosciences, Inc. $19.70 02/21/2024 Food and Beverage Undisputed 01/23/2026 1150860001 CMS
Neurocrine Biosciences, Inc. $105.70 04/09/2024 Food and Beverage Undisputed 01/23/2026 1150811739 CMS
Neurocrine Biosciences, Inc. $139.05 07/25/2024 Food and Beverage Undisputed 01/23/2026 1150807378 CMS
Neurocrine Biosciences, Inc. $21.31 08/15/2024 Food and Beverage Undisputed 01/23/2026 1150853727 CMS
Noven Therapeutics, LLC $13.99 08/26/2024 Food and Beverage Undisputed 01/23/2026 1084819912 CMS
Tris Pharma Inc $83.12 05/14/2024 Food and Beverage Undisputed 01/23/2026 1147231281 CMS
Vanda Pharmaceuticals Inc. $12.48 02/12/2024 Food and Beverage Undisputed 01/23/2026 1133918525 CMS
Vanda Pharmaceuticals Inc. $12.61 05/29/2024 Food and Beverage Undisputed 01/23/2026 1133918527 CMS
Vanda Pharmaceuticals Inc. $7.63 06/27/2024 Food and Beverage Undisputed 01/23/2026 1133918529 CMS
Vanda Pharmaceuticals Inc. $13.10 07/18/2024 Food and Beverage Undisputed 01/23/2026 1133918531 CMS
Vanda Pharmaceuticals Inc. $119.30 08/21/2024 Food and Beverage Undisputed 01/23/2026 1133918533 CMS
Vanda Pharmaceuticals Inc. $12.44 08/22/2024 Food and Beverage Undisputed 01/23/2026 1133918535 CMS
Vanda Pharmaceuticals Inc. $7.26 11/21/2024 Food and Beverage Undisputed 01/23/2026 1133918537 CMS
Vanda Pharmaceuticals Inc. $119.59 12/11/2024 Food and Beverage Undisputed 01/23/2026 1133918539 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.